home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  International Society for Experimental Hematology 31st Annual Meeting, Montreal, Canada  
  December 17, 2001

Others

 
     
  McGill University and Université de Montréal, Montreal, Canada
July 5-9, 2002


It is the belief of the organizing committee that this Meeting will be the"occasion to identify the most exciting new discoveries in hematopoiesis research, as well as to recognize the progress made in the last thirty years in our field. It will also serve to acknowledge the vitality of the Society in providing a forum among stem cell biologists and other scientists whose fields intersect with experimental hematopoiesis and stem cell transplantation. The areas of focus of the Scientific Program include stem cell proliferation, malignant transformation and targeted therapy, signalling in normal and malignant cells, marrow and cord blood stem cell transplantation, and gene function discovery and transfection.
 
 
Organized by: N. Dainiak/Chair, L. Busque, T. Hoang, S. Lachance, P. Laneuville/Co-Chair, S. Lehnert, P. Ponka, G. B. Price, D-C. Roy/Co-Chair
Invited Speakers: Welcome
Nicholas Dainiak, MD, Bridgeport Hospital, Yale University, McGill University, Bridgeport, CT
Esmail Zanjani, PhD, University of Nevada, Reno, NV

Metcalf Lecture
Rainer Storb, Fred Hutchinson Cancer Research Center, Seattle, WA
The ISEH thanks Amgen, Inc. for the support of the ISEH Metcalf Lecture & Award

Plenary Session 1
Stem Cell Differentiation and Apoptosis
1. Tariq Enver, PhD, Chester Beatty Institute of Cancer Research, London, UK
"Transcriptional Programming in Hematopoietic Stem Cells"
2. Harinder Singh, PhD, University of Chicago, Chicago, IL
"PU.1, a Transcriptional Regulator of Myelo and Lymphopoiesis"
3. Katia Georgopoulos, PhD, Massachusetts General Hospital, Charlestown, MA
"Ikaros, Chromatin Regulation, and Hemopoietic Lineage Decisions"
4. Norman Iscove, MD, PhD, Ontario Cancer Institute, Toronto, ON
"Differential Gene Expression in Homogeneously Pure Stem Cells and Downstream Progeny"
5. Shigekazu Nagata, PhD, Osaka University Medical School, Osaka, Japan
"DNA Degradation During Apoptosis and Erythropoiesis"

Plenary Session 2
Malignant Transformation and Targeted Therapy
1. Brian J. Druker, MD, Oregon Health Sciences University, Portland, OR
"CML: A Targeted Therapy: Lessons Learned"
2. Anthony R. Green, PhD, FRCP, University of Cambridge, Cambridge, UK
"Deletions of the Derivative Chromosome 9 in CML - Double Jeopardy from a Single Translocation"
3. Guy Sauvageau, MD, Clinical Research Institute of Montreal, Montreal, QC
"Molecular Dissection of Hox-induced Leukemia"
4. David Roodman, MD, PhD, University of Pittsburgh Cancer Institute, Pittsburgh, PA
"Role of MIP-1 alpha in Bone Destruction and Tumor Burden in Myeloma"

Plenary Session 3
Signalling in Normal and Malignant Cells
1. Antonio Lanzavecchia, MD, Institute for Research in Biomedicine, Bellinzona, Switzerland
"The Cellular Basis of Immunological Memory"
2. Carl H. June, MD, University of Pennsylvania, Pittsburgh, PA
"Adoptive Immunotherapy with Th1, Th2 and T Regulatory T Cells"
3. Gerry Krystal, PhD, Terry Fox Laboratory, University of British Columbia, Vancouver, BC
"The Role of SHIP in Hemopoietic Cell Signalling"
4. Trang Hoang, PhD, Clinical Research Institute of Montreal, Montreal, QC
"The Role of SCL in Erythroid Differentiation and Leukemia"

Plenary Session 4>
Marrow and Blood Stem Cell Transplantation
1. Saul J. Sharkis, PhD, Johns Hopkins Oncology Center, Baltimore, MD
"Potentials for Tissue Repair by Hematopoietic Stem Cell Transplant"
2. Stephen Forman, MD, City of Hope National Medical Center, Duarte, CA
"Non-Myeloablative Stem Cell Transplantation"
3. Norbert-Claude Gorin, PhD, Hôpital Saint-Antoine, Paris, France
"Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphomas"
4. Claude Perreault, MD, Maisonneuve-Rosemont Research Centre, Montreal, QC
"Extrathymic T lymphocyte Development"
5. Robert S. Negrin, MD, Stanford University, Stanford, CA
"Visualization of Tumor and Effector Cell Trafficking in Hematologic Malignancies"

Plenary Session 5
Gene Function Discovery and Transfection
1. John Tisdale, MD, National Institute of Health, Bethesda, MA
"Hematopoietic Stem Cell Gene Transfer: Prospects for Therapeutic Gene Delivery"
2. Stuart Orkin, MD, Children's Hospital & Dana Farber Cancer Institute, Boston, MA
"Control of Hematopoietic Lineage: Molecular Mechanisms and Implications"
3. Achim Leutz, MD, Max Delbruck Center for Molecular Medicine, Berlin, Germany
"Translation Initiation Control and Hematopoiesis"
4. Neal Copeland, PhD, National Cancer Institute, Frederick, MD
"Leukemia Disease Genes: Prospects for High Throughput Gene Function Discovery in the Modern Genome Era"
5. Timothy Ley, MD, Washington University Medical Center, St. Louis, MO
"Genetic Progression Factors for Murine Acute Promyelocytic Leukemia"

Plenary Session 6
Biology and Medicine of Cord Blood
1. Pablo Rubinstein, MD, Laboratory of Immunogenetics, New York Blood Center, New York, NY
"Cord Blood Transplantation: Clinical Outcomes and Factors Affecting Prognosis"
2. Peter Wernet, MD, Institute for Transplantation, Diagnostics and Cell Therapeutics, Dusseldorf, Germany
"Unrestricted Multipotential Stem Cells in Cord Blood: A Universal Donor Cell for Regenerative Medicine?"
3. Esmail Zanjani, MD, University of Nevada, Reno, NV
"In Vivo Engraftment and Differentiation Potential of Human Cord Blood Hematopoietic Stem Cells"
4. Peter Quesenberry, MD, Roger Williams Medical Center, Providence, RI
"The New Stem Cell Biology: Clinical Implications
 
Deadline for Abstracts: March 1, 2002
 
Registration: Early Registration - Before March 1, 2002:
ISEH Member, $350 US - Non-member, $485 US - Student, $130 US - Companion Adult, $215 US - Companion Youth, $160 US
Regular Registration - After March 1, 2002:
ISEH Member, $450 US - Non-member, $585 US - Student, $230 US - Companion Adult, $315 US - Companion Youth, $260 US
On-site Registration - After June 30, 2002:
ISEH Member, $550 US - Non-member, $685 US - Student, $330 US - Companion Adult, $415 US - Companion Youth, $360 US
E-mail: iseh2002@mcgill.ca
 
  Posted by:   John Honeyman for Joan Gross, McGill University  
Host: 198.168.189.166
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2002 HUM-MOLGEN. All rights reserved. Liability and Copyright.